HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.
![handle is hein.congrecreports/crptxadrg0001 and id is 1 raw text is: AUTHENTICATED
U.S. GOVERNMENT
INFORMATION
GP
116TH CONGRESS [REPT. 116-687
2d Session HOUSE OF REPRESENTATIVES Part 1
COMPREHENSIVE IMMUNOSUPPRESSIVE DRUG COV-
ERAGE FOR KIDNEY TRANSPLANT PATIENTS ACT OF
2020
DECEMBER 24, 2020.-Committed to the Committee of the Whole House on the State
of the Union and ordered to be printed
Mr. PALLONE, from the Committee on Energy and Commerce,
submitted the following
R E P O R T
[To accompany H.R. 5534]
[Including cost estimate of the Congressional Budget Office]
The Committee on Energy and Commerce, to whom was referred
the bill (H.R. 5534) to amend title XVIII of the Social Security Act
to provide for extended months of Medicare coverage of immuno-
suppressive drugs for kidney transplant patients, and for other
purposes, having considered the same, reports favorably thereon
with an amendment and recommends that the bill as amended do
pass.
CONTENTS
Page
I. Purpose and Sum m ary ............................................................................. 4
II. Background and Need for the Legislation .............................................. 4
III. Com m ittee H earings ................................................................................. 5
IV. Com m ittee Consideration ......................................................................... 6
V . Com m ittee V otes ....................................................................................... 6
VI. Oversight Findings .................................................................................... 6
VII. New Budget Authority, Entitlement Authority, and Tax Expenditures 6
VIII. Congressional Budget Office Estimate ...................................................... 7
IX. Federal M andates Statem ent .................................................................... 10
X. Statement of General Performance Goals and Objectives ....................... 10
XI. Duplication of Federal Program s .............................................................. 10
XII. Committee Cost Estimate .......................................................................... 10
XIII. Earmarks, Limited Tax Benefits, and Limited Tariff Benefits .............. 10
XIV. Advisory Committee Statement ................................................................ 10
XV. Applicability to Legislative Branch ........................................................... 10
XVI. Section-by-Section Analysis of the Legislation ......................................... 10
XVII. Changes in Existing Law Made by the Bill, as Reported ....................... 11
19-006](ViewImageLocal?handle=hein.congrecreports/crptxadrg0001&div=1&collection=&method=preview&ext=.png&size=3)